Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study by Alzamora, María Teresa et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Neurology
Open Access Research article
Ischemic stroke incidence in Santa Coloma de Gramenet 
(ISISCOG), Spain. A community-based study
María Teresa Alzamora*1,2,3, Marta Sorribes4, Antonio Heras1, Nicolás Vila†5, 
Marisa Vicheto1, Rosa Forés1, José Sánchez-Ojanguren6, Amparo Sancho7 for 
the "ISISCOG Study Group" and Guillem Pera3
Address: 1GPS Riu Nord-Riu Sud, Institut Català de la Salut, Major 49, 08921 Santa Coloma de Gramenet, Spain, 2Department of Medicine, 
Universitat Autònoma de Barcelona, Spain, 3Research Unit Barcelonés Nord Maresme, ICS-IDIAP Jordi Gol, Camí del Mig 36, 08303 Mataró, 
Spain, 4GPS Numància, Institut Català de la Salut, Numància 23, 08029 Barcelona, Spain, 5Unitat de Neurociències, Institut Català de la Salut, 
Hospital Germans Trias i Pujol, Carretera del Canyet s/n, Badalona, Spain, 6Esperit Sant Hospital, Mossen Pons i Rabadà s/n, 08923 Santa Coloma 
de Gramenet, Spain and 7GPS Can Mariné, Institut Català de la Salut, Sant Carles 79, 08921 Santa Coloma de Gramenet, Spain
Email: María Teresa Alzamora* - maiteal2007@gmail.com; Marta Sorribes - martasorribes.pbcn@ics.scs.es; 
Antonio Heras - aheras.bnm.ics@gencat.net; Nicolás Vila - med020228@nacom.es; Marisa Vicheto - mllvicheto.bnm.ics@gencat.net; 
Rosa Forés - rfores.bnm.ics@gencat.net; José Sánchez-Ojanguren - jsanchez@hes.scs.es; Amparo Sancho - asanchop.bnm.ics@gencat.net; 
Guillem Pera - gpera.bnm@ics.scs.es
* Corresponding author    †Equal contributors
Abstract
Background: In Spain, stroke is one of the major causes of death and the main cause of severe
disability in people over 65 years. We analyzed the incidence of ischemic stroke, stroke subtypes,
case fatality and disability at 90 days after the event in a Spanish population.
Methods: A prospective community-based register of ischemic strokes was established in Santa
Coloma de Gramenet (Barcelona) [116,220 inhabitants of all ages, according to the municipal
census of December 31,2001], from January 1 to December 31, 2003.
Standard definitions and case finding methods were used to identify all cases in all age groups. Every
patient underwent a complete clinical evaluation and systematic tests including neuroimaging (CT/
MRI) and vascular studies (carotid duplex ultrasound intra and extracranial and MR angiography).
Results: Over a one year period, 196 ischemic strokes were registered [107 men; median age =
76 years (range 39–98)], being the first event in 159 patients (81.1%) and a recurrent stroke in 37
(18.9%). After age-adjustment to the European population, the incidence of ischemic stroke per
100,000 inhabitants was 172 (95% CI, 148–196); 219 (176–261) in men and 133 (105–160) in
women, with an annual incidence for first ischemic stroke of 139 (118–161); 165 (128–201) in men
and 115 (89–140) in women. The incidence of stroke increased with age.
Stroke subtypes (TOAST classification criteria) were lacunar in 28.8%, atherothrombotic in 18.6%,
cardioembolic in 26.6% and undetermined in 26.0% of patients. At 90 days, the case-fatality was
12%, and among survivors, moderate-to-severe disability was present in 45 % at 3 months.
Conclusion: This prospective community-based study shows one of the lowest incidences of
stroke in Europe, as well as one of the lowest case fatality and disability rates at 90 days after stroke.
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Background
In Spain, stroke is the first cause of death in women and
the second in men, the main cause of severe disability in
people over the age of 65 years and the second cause of
dementia [1]. It has been predicted that the burden of
stroke will rise in the oncoming years because of the
increase in the elderly population in both the developed
and developing world.
The incidence of stroke is estimated to be about 150 per
100,000 people per year in developed countries [2]. In
Spain, the overall crude annual incidence of stroke was
174/100,000 and 132/100,000 inhabitants in two com-
munity studies [3,4]. The combined incidence of stroke
and transient ischemic attack was 200/100,000 inhabit-
ants [5,6].
Stroke is a disease with well-defined modifiable risk fac-
tors. Several interventions are effective in both the pri-
mary and secondary prevention of stroke and may reduce
the incidence of stroke by as much as 50–80% [7,8]. How-
ever, blood pressure is well controlled in less than 20% of
hypertensive patients in Spain and an important number
of patients abandon hypertensive treatment within 6
months [9]. Time-trends in stroke incidence and outcome
can be measured to assess the efficacy of preventive strat-
egies and the planning of healthcare and community
resources.
The present study was designed to analyze the incidence,
sub-typing, case fatality and disability 90 days after
ischemic stroke in an urban area of Spain using a multi-
center community-based register.
Methods
This study followed the criteria for "ideal" population-
based stroke studies published by Malmgren et al. in 1987
and later updated by Bonita et al. in 1995 and Sudlow and
Warlow in 1996 [10-14]. The study was approved by the
regional research Ethics Committee.
Study area and population
This prospective, population-based study was conducted
in the 6 primary health care centers and 2 hospitals in
Santa Coloma de Gramenet, an urban area of Barcelona,
Spain, from January 1, 2003 to December 31, 2003. The
study population (all residents in the community of Santa
Coloma de Gramenet) comprises 116,220 inhabitants of
all ages (58,115 males and 58,105 females) according to
the municipal census of December 31, 2001. The popula-
tion is Caucasian, of middle-low socio-economical level
with a high medical advice demand and a proportion of
inhabitants over 65 years of age of 15.7% (13.6% in men
and 17.8% in women), similar to the Spanish proportion
(17.1%) [15]. The whole population is covered by the
national health service. Primary health care in this area is
provided by 62 general practitioners (GPs) distributed in
6 primary health care centers. Specialized referral is pro-
vided by 2 hospitals (one tertiary university hospital and
one general community hospital) which are open 24
hours a day, 7 days a week. Non residents living in this
area during the ischemic event were excluded.
Case ascertainment
Several overlapping sources of information were used:
hospitals and primary health care centers. Cases were con-
secutively included. To identify patients admitted to the
two hospitals daily checks of hospital admission and dis-
charge records were made by the participating neurolo-
gists (N.V. and J.S.). For precise estimation of the number
of patients with non-fatal stroke managed outside the par-
ticipating hospitals, the GPs in the community of Santa
Coloma de Gramenet were notified of the study and regu-
larly asked to refer all patients with stroke to the Neurol-
ogy Units of the reference hospital for evaluation by the
same neurologists. The authors (M.V., R.F., M.S. and
M.A.) contacted GPs, nursing homes and geriatric or psy-
chiatric long-stay institutions monthly by e-mail, facsim-
ile or telephone calls to detect potential incident cases and
to encourage early notification to the coordinating centre.
In addition, a systematic search of primary care patient
databases in the study area was made to seek any patient
coded as stroke or acute cerebrovascular event. All patients
identified were subsequently reviewed by the investiga-
tors.
Every patient with a first-ever or recurrent ischemic stroke
during the study period was included as a case and was
prospectively evaluated. The final diagnosis and stroke
subtype classification was made by one of the two above
mentioned neurologists.
Study definitions and procedures
Diagnosis of stroke was defined according to the World
Health Organization (WHO): "rapidly developing clinical
signs of focal disturbance of cerebral function, lasting
more than 24 hours or leading to death with no apparent
cause other than that of vascular origin". This definition
excludes cases of "silent stroke" detected by neuroimaging
without appropriate clinical features and cases of transient
ischemic attacks (TIA) (neurological deficits lasting < 24
hours). Diagnosis was based on clinical findings and CT
brain imaging [16]. Stroke subtypes were classified fol-
lowing the TOAST criteria as lacunar, atherothrombotic,
cardioembolic and undetermined [17]. Ischemic stroke
was also classified into subtypes: occlusion and stenosis of
pre-cerebral arteries, occlusion of cerebral arteries, tran-
sient cerebral ischemia, acute.BMC Neurology 2008, 8:5 http://www.biomedcentral.com/1471-2377/8/5
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All events were categorized as first-ever or recurrent stroke
on the basis of clinical history rather than brain imaging
findings. Any stroke developing within 28 days of a previ-
ous event was considered as "progressing stroke" and was
not recorded as a new event while disturbances develop-
ing ≥ 28 days were regarded as a recurrent event [18].
"Attack rate" includes all stroke events (first-ever and
recurrent stroke), whereas "incidence rate" describes first-
ever stroke [18]. A first-ever stroke in a patient with a pre-
vious transient ischemic attack was coded as incident and
a new stroke in a patient with a previous stroke was coded
as recurrent. Neither new cases of "transient ischemic
attack" nor intracerebral hemorrhages were included in
this study.
Patient assessment
A combination of "hot pursuit" (prospective screening of
hospital admissions and referrals from GPs, nursing
homes and long-stay institutions) and "cold pursuit" (ret-
rospective identification of potential cases from hospitals
and Primary Health Centers medical records) was used to
determine patients with stroke.
Before patient registry, surviving patients received an
information letter and provided written consent to for
inclusion in the registry and to undergo follow-up. Family
consent (next of kin) was obtained from patients who
were severely ill or unconscious. All patients with sus-
pected stroke were transferred to one of the two participat-
ing hospitals and examined by the consulting
neurologists. Data on previous therapy, vascular risk fac-
tors and medical history were collected from medical
records. Systematic investigations included neurological
examination, 12-lead ECG, chest radiography, and rou-
tine blood tests including fasting glucose, cholesterol con-
centrations, and complete blood analysis. Non contrast
brain CT scan was performed immediately after hospital
admission in all patients. Control CT or MRI was per-
formed during the first two weeks of hospitalization to
confirm the ischemic lesion. On identification of a case,
data was manually introduced in a computer database
designed for this study.
Patients were followed by GPs until 3 months after stroke
onset. Case fatality was defined as the proportion of regis-
tered patients with stroke who died within 90 days of the
stroke. The cause of death was established by the GP certi-
fying death at home or was determined from all available
medical records on death in the hospital or a nursing-
home institution. There was no need to review death cer-
tificates since all were signed by the GPs or neurologists
(in-hospital death) participating in the study. Disability at
90 days was measured with the Barthel Index (BI) of daily
living activities [19]. The BI was evaluated by nurses who
attended patients at the primary health care centers,
patient homes or institutions, and classified as severe (<
60), moderate (60 to 85) and mild or no disability (90 to
100). The BI was not recorded in two patients who were
alive at the end of the follow-up.
Statistical analysis
Incidence rates and 95% confidence intervals (CI) were
calculated per 100,000 inhabitants. The denominator for
the calculation of the incidence rate was the updated cen-
sus data from the 2001 (116,202 inhabitants). Incidence
rates were calculated for the whole population and by sex
in the following age groups: < 45 years, 45 to 49, 50 to 54,
55 to 59, 60 to 64, 65 to 69, 70 to 74, 75 to 79, 80 to 84
and >=85 years. For comparison with other community-
based studies, the rates were adjusted to the 2001 Euro-
pean population [20].
Sex and age-specific stroke attack rates were calculated. To
compute incidence rates and their confidence intervals
(row and standardised) we used the statistical package:
CIA v1.0 (Professor MJ Gardner & BMJ, 1989). All confi-
dence intervals are at level of 95%.
Results
From January 1st to December 31st, 2003, 247 patients
with a suspected acute cerebrovascular event were identi-
fied. Most strokes were admitted to one of the two partic-
ipating hospitals (92%), but a few cases to nursing homes
or long-stay institutions (1 %), were reported directly by
primary health care center physicians (6%) or were admit-
ted to other hospitals outside the community (1%).
Screening of death certificates was not performed. After
comprehensive evaluation in all patients ischemic stroke
was diagnosed in 196 cases; 159 patients (81.1%) with a
first-ever ischemic stroke and 37 (18.9%) a recurrent
stroke. 51 patients were excluded because of intracerebral
hemorrhage (n = 50) or brain tumor (n = 1), thus, a total
of 196 patients with cerebral infarction were registered.
The cases included 107 males (55%) and 89 females
(45%) with a mean age of 74 years (71 for men and 78 for
women) and median age was 76 years (range 39 to 98).
Among cases, prevalences of several known risk factors
were: prior TIA (6%), hypertension (66%), dyslipidemia
(31%), current smoker (16%), diabetes mellitus (34%),
peripheral arterial disease (6%), atrial fibrillation (26%),
angina (10%), myocardial infarction (11%), and sleep
apnea (5%).
The global incidence for ischemic stroke was 169/100,000
(95% CI, 145–192), and the crude annual incidence for
first-ever ischemic stroke was 137/100,000 (95% CI, 116–
159). The age-specific annual attack and incidence rates of
ischemic stroke are shown in tables 1 and 2, respectively.
After age-adjustment to the 2001 European population,BMC Neurology 2008, 8:5 http://www.biomedcentral.com/1471-2377/8/5
Page 4 of 8
(page number not for citation purposes)
the incidence for ischemic stroke was 172 (95% CI, 148–
196) per 100,000 inhabitants; 219 (176–261) in males
and 133 (105–160) in females and the annual incidence
for first-ever ischemic stroke was 139 (95% CI, 118–161)
per 100,000 inhabitants; 165 (128–201) in males and
115 (89–140) in females. The incidence rate increased
with age, with 4 cases per 100,000 individuals in subjects
under 45 years of age, 58 in those from 45–49 years, 135
in the 50–54 year-old group, 105 from 55–59 years, 271
from 60–64 years, 276 from 65–69 years, 788 from 70–74
years, 1112 from 75–79 years, 1338 from 80–84 years,
and 1610 in subjects ≥ 85 years. This increase in incidence
with age was observed in both sexes, with a higher inci-
dente in males in all age groups.
A brain CT scan was performed immediately after hospital
admission in all patients. Control CT scan was performed
during the first two weeks of hospitalization in 110
patients (56%), and MRI in 90 patients (46%). Other
examinations included 12-lead ECG in 192 patients
(98%), transthoracic echocardiography in 86 patients
(44%), carotid Dupplex ultrasound intra and extracranial
in 159 patients (81%) and MR angiography in 9 patients
who also underwent the ultrasound study. According to
the TOAST classification, 37 (18.6%) patients presented a
large artery atherothrombotic stroke, 52 (26.6%) a cardi-
oembolic stroke, 56 (28.8%) a lacunar stroke and 51
(26.0%) a stroke of undetermined origin.
Table 1: Age- and sex-specific attack rates of ischemic stroke per 100,000 population of Santa Coloma de Gramenet, Spain, 2003.
Age (years) Men Women Total
Events/at risk Rate (95% CI) Events/at risk Rate (95% CI) Events/at risk Rate (95% CI)
< 45 3/35418 8 (0–18) 0/32375 - 3/67793 4 (0–9)
45–49 2/3350 60 (6–214) 2/3489 57 (6–201) 4/6839 59 (1–116)
50–54 8/3816 210 (92–409) 3/4340 69 (0–147) 11/8156 135 (55–215)
55–59 8/4186 191 (59–323) 1/4369 23 (0–68) 9/8555 105 (37–174)
60–64 14/3445 406 (226–677) 4/3197 125 (31–323) 18/6642 271 (146–396)
65–69 9/3074 293 (128–555) 8/3081 260 (116–507) 17/6155 276 (145–407)
70–74 23/2129 1080 (690–1620) 13/2440 533 (287–909) 36/4569 788 (532–1040)
75–79 18/1381 1300 (775–2060) 20/2037 982 (604–1510) 38/3418 1110 (787–1520)
80–84 12/773 1550 (800–2690) 17/1394 1220 (714–1950) 29/2167 1340 (897–1910)
≥ 85 10/543 1840 (885–3360) 21/1383 1520 (946–2310) 31/1926 1610 (1090–2280)
Row/Crude 107/58115 184 (149–219) 89/58105 153 (121–185) 196/116220 169 (145–192)
Standardised (Europe) 219 (176–261) 133 (105–160) 172 (148–196)
CI = Confidence Interval
Table 2: Age- and sex-specific annual incidence rates of first-ever ischemic stroke per 100,000 population of Santa Coloma de 
Gramenet, Spain, 2003.
Age (years) Men Women Total
Events/at risk Rate (95% CI) Events/at risk Rate (95% CI) Events/at risk Rate (95% CI)
< 45 3/35418 8 (0–18) 0/32375 - 3/67793 4 (0–9)
45–49 2/3350 60 (6–214) 1/3488 29 (6–165) 3/6838 44 (0–93)
50–54 7/3815 183 (79–372) 2/4339 46 (0–110) 9/8154 110 (38–182)
55–59 6/4184 143 (29–258) 1/4369 23 (0–68) 7/8553 82 (21–142)
60–64 13/3444 377 (201–641) 4/3197 125 (30–323) 17/6641 256 (134–378)
65–69 6/3071 195 (67–421) 8/3081 260 (116–507) 14/6152 228 (108–347)
70–74 17/2123 801 (470–1280) 11/2438 451 (226–812) 28/4561 614 (387–841)
75–79 13/1376 945 (507–1610) 17/2034 836 (482–1340) 30/3410 880 (592–1250)
80–84 9/770 1170 (531–2200) 15/1392 1080 (604–1780) 24/2162 1110 (714–1640)
≥ 85 6/539 1110 (409–2410) 18/1380 1300 (775–2060) 24/1919 1250 (800–1850)
Row/Crude 82/58090 141 (111–172) 77/58093 133 (103–162) 159/116183 137 (116–158)
Standardised (Europe) 165 (128–201) 115 (89–140) 139 (118–161)
CI = Confidence IntervalBMC Neurology 2008, 8:5 http://www.biomedcentral.com/1471-2377/8/5
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Two patients (1.26%) were lost to follow up within the
first 90 days after the event. Among survivors at 3 months,
severe disability was present in 21.9% (95% IC:15.4–
28.5), moderate disability in 22.6% (95% IC:16.0–29.2)
and mild or non-disability in 55.5% (95% IC:47.7–63.3).
Severe disability increased with age, from 1.16% in people
younger than 50 up to 8.73% in people with 75–85 years.
However, this trend was broken for people older than 85
(5.24%). The same trend was found for moderate disabil-
ity: 0.58% among younger than 50 up to 19.11% among
people 75–85 years old, 2.33% in people older than 85.
The case fatality at 90 days was 12% (95% CI: 7–17),
being higher in women (60% of total cases). We found
the following mortality rates at 90 days by age: 15% (< 65
years), 10% (66–75), 45% (76–85) and 30% (> 85). 50%
of death occurred in the first month, 40% at the second
month and 10% at the third month.
Discussion
To our knowledge, this is the first community-based study
on ischemic stroke in Spain using "hot pursuit" and "cold
pursuit", in a geographic area with a large, stable, well-
defined population and a close relationship between hos-
pital neurology departments and GPs using standard and
accepted tests for the diagnosis of stroke in all patients.
Prior stroke incidence in a Spanish population was esti-
mated at between 163 and 257 cases per 100,000 inhabit-
ants with a crude annual incidence rate for first-ever stroke
from 132 and 174 cases [3,5], although these studies did
not follow the "ideal" criteria proposed by Malmgrem,
Bonita, Sudlow and Warlow [10-13]. Our study shows a
crude annual incidence rate for first-ever ischemic stroke
of 137 cases per 100,000 inhabitants, being one of the
lowest reported in community-based studies using similar
methodology, even when standardized to the European
population (table 3).
Arterial hipertensión was the most prevalent cardiovascu-
lar risk factor in these patients similar to the results of
most studies [14].
Determination of the incidence of ischemic stroke in our
area may be of interest to monitor possible differences in
different European regions. Another point of note is that
the probability of having a stroke is normally calculated
with the Framingham equation. However, the REGICOR
study carried out in Spain [21] has demonstrated that this
equation, estimated in the American population, overesti-
mates the risk of vascular events in European populations,
especially in the Mediterranean peoples. Thus, the real
incidence of stroke in our country may be lower than that
of other European countries. Moreover, this study will be
useful to monitor the evolution of incidence, case fatality
and disability of our population since, after having under-
taken this study, an Institutional Plan has been imple-
mented for protocolized and emergency care to patients
with stroke. This will undoubtedly have a positive influ-
ence on the evoluation of this disease as has been demon-
strated in other studies published in the literature [14].
Due to the increasing age of the general population in our
country, it is important to obtain information in old and
very old patients (> 84 years old), in order to provide ade-
quate health care services and to plan socioeconomic
resources. Accordingly, was not restricted to any group of
age. In fact, 16% of all strokes were observed in patients
over the age of 84 years, representing 1.7% of the popula-
tion in our area [3,18,22].
In this study only 8% of patients were not-admitted to
hospital in the acute phase of stroke, a proportion similar
to that observed in many other developed countries, espe-
cially in urban areas [23-35]. This is in accordance with
the Helsinborg Statement that defines stroke as an emer-
gency and points out the need for all patients to be rapidly
hospitalized in specialized care units after the onset of
symptoms [30,31,34].
The present study shows a mortality rate lower than that
reported in prior population-based studies [3-5].
Although several factors not assessed in the present study
may explain these differences, mortality and dependency
have been reduced in recent because of improvement in
the general management and care of acute stroke patients
[32-34]. An important effort has been made to avoid
underestimation of stroke incidence, combining "hot and
cold pursuit" and contacting all the GPs, nursing homes
and long-stay institutions in addition to an exhaustive
scan of medical and admission records. Correct case ascer-
tainment has been achieved using 2 expert neurologists
and CT scan in all cases.
Diagnosis was based on clinical findings and CT brain
imaging. A CT scan was performed in 100% of the cases,
and a control CT scan was performed in the 56% of
patients. Magnetic resonance imaging was carried out in
46%. On suspicion of different subtypes of stroke, an MRI
is more indicated than a CT scan. In 2 % of the cases both
imaging tests were required.
Comparison between this and other epidemiological
studies [3-5] carried out in our country is difficult due to
differences in the time periods studied (in the last decades
confirmation of diagnosis with neuroimaging techniques
has varied markedly), as well as in methodologies imple-
mented. In the ISISCOG study, cranial CT was used in 100
% of the cases while cerebral CT was only performed in 70
% of the cases studied by Caicoya et al. [4], in 72 % of the
patients included by Jover et al. [5] and the percentage ofB
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Table 3: Annual incidence rate cerebral infarction and adjusted annual incidence rate ischaemic stroke.
Study Oxford Community 
Stroke Project
MONICA Perth Community 
Stroke Study
ARIC INNHERRED ERLANGEN L'AQUILA South London 
Stroke Register
Oxford Vascular 
Study
ISISCOG
Year 1981–84 1985–87 1989–90 1987–95 1994–96 1994–96 1994–98 1995–98 2002–04 2003
Place UK Europe & 
China
Australia USA Norway Germany Italy UK UK Spain
n (population) 86,487 2,900,000 138,704 15,792 70,000 101,450 297,838 234,533 90,542 116,202
Age (years) No age restriction 35–64 No age restriction 45–64 ≥ 15 No age restriction No age restriction - No age restriction No age 
restriction
Mean Age (years) 67.4 - 72.7 - - - 74.8 71.7 74.1 74
Overall Stroke (for 
100,000)
227 101–285 
men 47–198 
women
258- - 312 285 men 338 
women-
- 275 - 162 -
Incidence rate 
cerebral infarction 
(for 100,000)
193 - 178 189 men 166 
women-
- 232 119 men 154 
women
221 men 220 
women
- 142 137 141 men 
133 women
Adjusted Incidence 
rate ischemic stroke 
(for 100,000)
- - World 132 men 77 
women
180 women - European 134 European 228 European128 World 
83
- European 
139 World 
65
CT based diagnoses 
(%)
98 - - CT scan: 84 
MRI: 27
87.5 95 89 CT/MRI: 88.3 - 100
30 day case fatality 
(%)
17.8 30 22 7.6 19.2 19.4 25.6 25.7 17.2 -
90 day case fatality 
(%)
. - - - - 28.5 - 32.9 - 12BMC Neurology 2008, 8:5 http://www.biomedcentral.com/1471-2377/8/5
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cranial CT carried out in the study by Lopez Pousa et al.
was not reported [3]. In this latter study only 35 % of the
patients with stroke were hospitalized which may nega-
tively influence the functional prognosis and mortality of
these patients. In the study by Jover et al. 62.6 % of the
patients were admitted to hospital, although this was not
a populational study since only patients attended in the
emergency department were studied [5]. The different per-
centages of hospital admissions have varied over time in
our country, which may reflect both health care education
of the patient and that of the professional as well as the
policy of patient admission at a hospitalary level in the
different decades.
Stroke subtypes according to the TOAST classification
were similar to those observed in other European coun-
tries [23,25,26]. As expected, the proportion of lacunar
stroke subtype was lower in the ISISCOG study than in the
ARIC study due to differences in the prevalence of hyper-
tension and hypertension control in Europe and the
United States [33,36].
The proportion of recurrent strokes (18.4%) during the
study period was lower than in the Erlanger study (23.0%)
in Germany [26] and the Innherred study (27.2%) in Nor-
way [29].
The case fatality at 90 days was 12% (95% CI: 7–17),
being higher in females (60% of total cases). We believe
data collection on case fatality and disability to be cor-
rectly registered, despite not having reviewed the death
certificates since autopsies are not routinely undertaken in
all deaths in Spain and the death certificates were signed
by the GPs or neurologists (in hospital deaths) participat-
ing in the study. Moreover, we determined the number of
survivors at 90 days with the follow up using the Barthel
Index.
Among survivors at 3 months, severe disability was
present in 21.9%, moderate disability in 22.6% and mild
or non-disability in 55.5%. Two patients were lost to fol-
low up among the survivors in the first 90 days. All survi-
vors (except the latter two) performed the Barthel test to
determine the grade of dependence by telephone inter-
view or personally if the patient was unable to respond by
telephone. The loss to follow up was due to the transfer of
the patients to other provinces in which the patients could
not be reached by telephone to perform the Barthel Index.
Case fatality and disability may have been influenced by
the possibility of receiving specialized health care early
since the population studied was an urban population
located with 20 minutes from an acute care hospital with
a neurology department.
The first limitation of the study may be the exclusive col-
lection of ischemic stroke. Another limitation may be the
diferent sources of the information on the denominator
and the numerator. When a stroke case is detected and the
clinical history reveals that this person had a stroke before
the study started, this would no longer be considered a
first stroke. However, this person should also be excluded
from the denominator, because he/she was not at risk of
first stroke at the time of the initiation of the study. This
could artificially make stroke rates lower than they actu-
ally are, for instance, in comparison to follow-up studies
in which information from the population and the out-
come comes from the same source. Nonetheless, we
believe that this is not a large problem and probably has
only a limited impact on the results.
Conclusion
In summary, this prospective community-based study
shows a lower age-adjusted incidence of stroke in north-
eastern Spain than other European studies and a lower
case-fatality at 90 days after stroke. These findings have
established the bases in order to determine changes in
stroke incidence in the next years. Recently a new acute
stroke unit has been implemented in our area, just after
this study was carried out. Studies of time-trends in stroke
incidence are required to ascertain whether the imple-
mentation of primary prevention strategies and an acute
stroke unit in our area are associated with a potential fall
in stroke incidence, disability and case fatality.
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